Skip to main navigation. Enzon Pharmaceuticals, Inc. manages its sources of royalty revenues from existing licensing arrangements with other companies primarily related to sales of certain drug products that utilize our proprietary technology. Mar 30, 2018 12:36 AM EDT. 15 minute delayed data.
http://investor.enzon.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.2 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
13
SSL
EXTERNAL LINKS
6
SITE IP
199.239.182.81
LOAD TIME
0.232 sec
SCORE
6.2
Investor Relations | Enzon Pharmaceuticals | investor.enzon.com Reviews
https://investor.enzon.com
Skip to main navigation. Enzon Pharmaceuticals, Inc. manages its sources of royalty revenues from existing licensing arrangements with other companies primarily related to sales of certain drug products that utilize our proprietary technology. Mar 30, 2018 12:36 AM EDT. 15 minute delayed data.
investor.enzon.com
Request Information — Enzon
http://investor.enzon.com/investorkit.cfm
To receive printed material by postal mail, please complete the following form. *. Please send me *. Investor Kit (includes recent press releases). 2010 Annual Report and Form 10-K. UPS Next Day Air. Required for express delivery. Type in number *. This helps Enzon Pharmaceuticals Inc. prevent automated submissions. I am interested in receiving investor relations notifications. *.
Enzon Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards (NASDAQ:ENZN)
http://investor.enzon.com/releasedetail.cfm?ReleaseID=844504
Laquo; Previous Release. May 1, 2014. Enzon Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards. PISCATAWAY, N.J. Enzon Pharmaceuticals, Inc. Enzon" or the "Company") (Nasdaq:ENZN) announced today that its Board of Directors (the "Board") has adopted a stockholder rights plan (the "Rights Plan") in an effort to preserve the value of its net operating loss carryforwards ("NOLs") under Section 382 of the Internal Revenue Code (the "Code"). April 30, 2014. May 14, 2014.
Annual Reports — Enzon
http://investor.enzon.com/annuals.cfm
Add file to Briefcase.
Briefcase Registration — Enzon
http://investor.enzon.com/briefcase.cfm
Collect, zip and download files from our Investor Relations website. Click on the briefcase icon. Located near most downloadable files throughout our IR website and use this page to manage your briefcase. Please fill in the form below to access this feature. *. Type in number *. This helps Enzon Pharmaceuticals Inc. prevent automated submissions.
Press Releases — Enzon
http://investor.enzon.com/releases.cfm
Enzon Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards. May 1, 2014. PISCATAWAY, N.J.- (BUSINESS WIRE)- Enzon Pharmaceuticals, Inc. ("Enzon" or the "Company") (Nasdaq:ENZN) announced today that its Board of Directors (the "Board") has adopted a stockholder rights plan (the "Rights Plan") in an effort to preserve the value of its net operating loss carryforwards ("NOLs") under Sec. Apr 23, 2013. Enzon Reports Fourth Quarter and Full Year 2012 Results. Mar 18, 2013.
TOTAL PAGES IN THIS WEBSITE
13
Executive Team — Enzon
http://enzon.com/docs/about_team
George W. Hebard III, M.B.A. Interim Principal Executive Officer, Interim Chief Operating Officer and Secretary. Richard L. Feinstein. Vice President - Finance and Principal Financial Officer.
About Enzon — Enzon
http://enzon.com/docs/about_overview
Enzon Pharmaceuticals, Inc. receives royalty revenues from existing licensing arrangements with other companies primarily related to sales of four marketed drug products, namely, PegIntron , Sylatron , Macugen and CIMZIA . The primary source of the Company’s royalty revenues is sales of PegIntron, which is marketed by Merck and Co., Inc.
Board of Directors — Enzon
http://enzon.com/docs/about_directors
Odysseas Kostas, M.D. Jennifer I. McNealey.
TOTAL LINKS TO THIS WEBSITE
6
Investor Relations | EnerNOC, Inc.
Skip to main content. How You Buy It. How Much You Use. When You Use It. Who We Work With. How You Buy It. How Much You Use. When You Use It. WHO WE WORK WITH. How You Buy It. How Much You Use. When You Use It. Who We Work With. Aug 7, 2015 at 4:00 PM ET. Intraday data provided by eSignal. EnerNOC, Inc. (NASDAQ: ENOC. Press Releases View all. Aug 6, 2015. EnerNOC Reports Results for Second Quarter of 2015. Jul 28, 2015. EnerNOC to Present at Upcoming Investor Conferences. Events and Presentations View all.
Investor Relations | Enphase Energy
Enphase Energy delivers energy management technology for the solar industry that increases energy production, simplifies design and installation, improves system uptime and reliability, reduces fire safety risk and provides a platform for intelligent energy management. Its semiconductor-based microinverter system converts energy at the individual solar module level and brings a system-based high-technology approach to solar energy generation, storage, control and management. Day High: 4.83. Mar 29, 2018.
The Ensign Group, Inc. - Investor Relations
This site requires Adobe Flash Player. View all ». Details on upcoming events are not yet available. View all ». Aug 4, 2015. The Ensign Group Reports Quarterly Adjusted Earnings of $0.60 per Share; Increases 2015 Guidance. Aug 4, 2015. The Ensign Group Acquires Two California Assisted Living Facilities. View all ». Aug 5, 2015 at 10:00 AM PT. The Ensign Group, Inc. Second Quarter FY15 Earnings Conference Call. May 7, 2015 at 10:00 AM PT. CareTrust REIT, Inc. Form 10 Filing. Stock Quote (NASDAQ: ENSG).
Investors | Entegris, Inc.
Skip to main navigation. Executives and Board of Directors. Annual Reports and Proxies. VP, Investor Relations. 1 978 436 6750. Entegris (NasdaqGS: ENTG) is a leader in yield-enabling products and materials for semiconductor and other advanced manufacturing environments. Headquartered in Billerica, Massachusetts, with manufacturing, laboratory, sales, and support facilities around the globe, Entegris is helping to make tomorrow’s technology products affordable and available today. Entegris has one of the...
Overview | Investors | Enumeral
Data as of 01/12/17 9:30 am ET. There are currently no events scheduled. Enumeral Completes Successful Warrant Tender Offer and Receives $3.4 Million in Gross Proceeds. Enumeral Reports Third Quarter Financial Results. Enumeral Appoints Wael Fayad as Chairman, President and Chief Executive Officer. Data provided by Nasdaq. Minimum 15 minutes delayed. Cambridge, MA 02140. 2017 Enumeral Biomedical Holdings, Inc.
Investor Relations | Enzon Pharmaceuticals
Skip to main navigation. Enzon Pharmaceuticals, Inc. manages its sources of royalty revenues from existing licensing arrangements with other companies primarily related to sales of certain drug products that utilize our proprietary technology. Mar 30, 2018 12:36 AM EDT. 15 minute delayed data.
Equifax Inc. - Investor Relations
Annual Shareholder Meeting Materials. Earnings Call and Presentations. Online Electronic Delivery Enrollment. Investor Relations Streaming Video. Technology and Analytical Services. Jul 26, 2015. National Consumer Credit Trends Report Q2 2015 Investor Version. Apr 23, 2015. National Consumer Credit Trends Report Q1 2015 Investor Version. Mar 20, 2015. Mar 20, 2015. Feb 26, 2015. National Consumer Credit Trends Report Q4 2014 Investor Version. Sep 30, 2014. Q3 2014 Form 10-Q. Jun 30, 2014. Feb 28, 2014.
Overview - Equinix
United States - English. United Kingdom - English. United States - English. Customer Portal (U.S.). Former Switch and Data. Where global business and growth connect. See how Equinix's global Interconnection data center platform connects companies to accelerate business performance. Equinix is the preferred global infrastructure platform for the worldâ s most demanding businesses. Cloud and IT Services. Content and Digital Media. Our global reach allows your expanding business to scale rapidly worldwide.
Investor Overview › Investor Relations › Equity Bank
Planning for the Future. Stock Quote and Chart. Q4 2016 Equity Bancshares Inc. Earnings Conference Call. 160;at 9:00 am CT. Q4 2016 Equity Bancshares Inc. Earnings Conference Call. Friday, January 27, 2017 . 9:00 am CT . Click here for webcast. Click here to add this event to your calendar. Data as of 01/11/17 4:00 pm ET. Equity Bancshares, Inc. Will Announce 2016 Results on January 26, 2017. Equity Bancshares, Inc. Completes $35 Million Private Placement of Common Stock. 01/27/17 9:00 am CT.
ERF Wireless Inc - Investor Relations
Articles of Incorporation (PDF). Board of Directors (PDF). Code of Conduct (PDF). Stock Quote (OT: ERFB). 3:53 PM ET on Aug 5, 2015. Delayed at least 20 minutes. ERF Wireless Inc. is a fully reporting public company trading on the NASDAQ electronic OTC bulletin board exchange under the symbol ERFB. The market for wireless broadband products and services has grown dramatically over the past few years and is expected to dominate all wireless markets in the future. While it is acceptable for Internet connec...
Esprinet S.p.A. - IT & Consumer Electronics Wholesaler - Investor Relations
Fai business con noi. Registrandosi è possibile personalizzare la disposizione dei contenuti trascinandoli nella posizione preferita. Password / Conferma password:. In questa sezione sono disponibili per gli investitori tutte le informazioni sull'andamento del titolo Esprinet, il calendario degli eventi finanziari e le comunicazioni finanziarie dell'azienda. Registrandosi al nostro sito Investor Relations. Il modello di business. Clienti e fornitori (Mix). Relazione sulla Corporate Governance. Esiste la ...
SOCIAL ENGAGEMENT